Send a Tweet
Most Popular Choices
Share on Facebook 21 Share on Twitter Printer Friendly Page More Sharing
Sci Tech   

National Geographic: How mRNA Vaccines Work and What the Latest Developments Mean.

Author 512932
Message Al Hirschfield
Become a Fan
  (3 fans)

A PROMISING CORONAVIRUS vaccine candidate cleared a key hurdle this week, when Moderna Therapeutics entered phase two of clinical trials. The move signals that the company’s mRNA vaccine has passed its initial safety checks and has met an important milestone in bringing this drug closer to the public and commercial markets.

After almost five months of global deaths and economic shutdowns wrought by the COVID-19 pandemic, people are anxiously awaiting a glimmer of hope for a return to normal routines. This partly explains the recent frenzy over results from Moderna and its frontrunner candidate, which moved from the company’s lab in Cambridge, Massachusetts, to human trials in a record-setting 63 days.

Image Deleted Because Wiki Page Empty or Removed Image

Read the rest of the story HERE:

At www.nationalgeographic.com

 

Rate It | View Ratings

Al Hirschfield Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

A rapidly aging boy from NJ, with a somewhat radical political bent, and stubbornly persistent anger issues...

The above photo is not of me but of an Indian holy man named Sathya Sai Baba. He is pictured here (in a photo taken in the (more...)
 

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation: